A B S T R A C T The X-linked lymphoproliferative syndrome is characterized by immunodeficiency to Epstein-Barr virus (EBV) manifested by severe or fatal infectious mononucleosis and acquired immunodeficiency. We studied immune responses in six males of a well-characterized kindred with the X-linked lymphoproliferative syndrome. Two males were studied before and during acute fatal EBV infection. Both individuals demonstrated normal cellular and humoral immunity before EBV infection. During acute EBV infection, both individuals developed vigorous cytotoxic cellular responses against EBV-infected and -iipinfected target cells. Anomalous killer and natural killer T cell activity was demonstrated against a va'-riety of lymphoid cell lines, autologous fibroblasts and autologous hepatocytes. Effector cells responsible for anomalous killing reacted with a pan-T cell monoclonal antibody, and belonged to the OKT.8 T cell subset. Death in each case was caused by liver failure, but one patient developed extensive liver necrosis, whereas the other developed a massive infiltration of the liver with EBV-infected immunoblasts after aggressive immunosuppressive therapy. Immunological studies were performed on four males who had survived EBV infection years previously. They demonstrated global cellular immune defects with deficiencies of lymphocyte proliferative responses to mitogens and antigens, humoral immune deficiencies, abnormalities of regulatory T cell subsets and deficient natural killer cell activity. We propose that an aberrant immune response triggered by acute EBV infection results in unregulated anomalous killer and natural killer cell activity against EBV infected and uninfected cells. These studies suggest that global immune defects appearing in males with X-linked lymphopro-
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bers of this family were studied before their encounter with EBV and during the acute phase of a fatal EBVinduced illness. Functional T lymphocytes and natural killer-cell populations were present before acute illness. Vigorous killer-cell activity accompanied acute exposure to EBV. Death in each case was primarily due to liver failure. Four males who survived their acute EBV infection were studied and demonstrated abnormal T cell and natural killer (NK) cell function. We propose that defective regulation of cytotoxic responses triggered by EBV-infected B cells results in fatal infectious mononucleosis or, in those who survive, immune deficiency.
METHODS Patients
Each patient studied is a member of a well-characterized kindred with the XLP described by Purtilo et al. (5) in 1977.
An updated pedigree is shown in Fig. 1 An autopsy showed widespread evidence of lymphoproliferation. The liver was enlarged and massively infiltrated with immunoblasts consistent with the diagnosis of immunoblastic sarcoma. Liver necrosis was also present, but to a lesser degree than observed in case 1.
Males surviving acute EBV infection
Case 3 (IV-32). A 21-yr-old male experienced an illness compatible with mononucleosis at age 10 yr. After this illness, the patient suffered repeated pulmonary infections. At age 17, he was found to be hypogammaglobulinemic and begun an intramuscular gamma globulin therapy. Over the past 4 yr, the patient has been free of significant pulmonary infections.
Case 4 (IV-51). This 21-yr-old male was well until 6 mo of age when he developed a syndrome characterized by fever, pneumonia, and hepatosplenomegaly. He was hospitalized and during the first week of illness, he became more severely ill and developed aseptic meningitis and anterior uveitis. His leukocyte count ranged from 6,000 to 22,000 mm3 with many atypical lymphocytes and he was severely anemic with a hematocrit of 18 . A heterophile antibody titer was negative. Bone marrow examination revealed infiltrating lymphocytes and a liver biopsy revealed periportal lymphoid infiltrations. During his hospitalization, he was initially treated with broad spectrum antibiotics and later corticosteroids. Over a 3-wk period, his illness gradually resolved and he was discharged to home. From this period on, the patient suffered recurrent bouts of suppurative otitis media and bacterial pneumonia. At age 16, the patient was found to have severe bronchiectasis and hypogammaglobulinemia. Immunoglobulin levels were IgG, 89 mg/dl; IgA, 23 mg/dl; IgM, 57 mg/dl. The patient was begun on intramuscular gamma globulin therapy and over the past 5 yr, he has been clinically well with occasional minor illnesses.
Case 5 (IV-54). A 23-yr-old white male was diagnosed as having a lymphoma of the ileum at age 12, which was treated with surgery and radiation. He has completely recovered and has not suffered any serious bouts with infections.
Case 6 (IV-56). A 15-yr-old white male experienced acute EBV infection at age 10, which was manifested by mild lymphadenopathy, rash, and sore throat. Hypogammaglobulinemia was discovered at the time of his acute infection. He has remained mildly hypogammaglobulinemic but has not suffered any significant recurrent infections.
Cell preparations
Peripheral blood mononuclear cells (PBMC) were obtained from heparinized venous blood and separated by Ficoll-Hypaque (Pharmacia Fine Chemicals, Inc., Piscataway, NJ) density-gradient centrifugation. PBMC were cultured in Hepes-buffered RPMI 1640 medium supplemented with 20% fetal calf serum (FCS), 100 U/ml penicillin, and 100 gg/ml streptomycin. PBMC preparations contained 70-80% lymphocytes, 10 Bulk T cell cultures were prepared by placing 0.5-1.0 X 106 PBMC in 2 ml of medium containing 30% purified lectin-free T cell growth factor (provided by Dr. Kendall A. Smith, Dartmouth Medical School, Hanover, NH). T cell growth was monitored with the use of an inverted microscope and bulk cultures were analyzed by morphology, staining reactions with monoclonal antibodies, and functional studies.
Some studies were performed on cryopreserved PBMC that were frozen using a Planer controlled rate cell freezer (Planer mini-freezer, model R202/200R, Polaron Instruments, Inc., Doylestown, PA).
Surface marker analysis PBMC were analyzed for the following surface markers: E-rosette formation, C3-rosette formation, Fc receptors, and surface membrane Ig (8) . T cell populations were enumerated using indirect immunofluorescence and the monoclonal antibodies T101 (pan T cell, Hybritech, Inc., La Jolla, CA); OKT.4 (T helper/inducer), OKT 
Statistical analysis
Logarithmic transformation of the data was used for calculation of the means, variance, standard deviation, and the t statistic. These are expressed as geometric means, 95% confidence intervals, and coefficients of variations and P values.
Cytotoxicity studies
Cell-mediated cytotoxicity was determined against EBVinfected and NK-sensitive target cells (12, 13) . Target cells consisted of cell lines 8392 and 8402 for EBV-specific cytolysis (11) . NK cell targets consisted of cell line K562, Daudi, and herpes simplex virus-infected fibroblasts (13, 14) . In selected experiments, target cells consisted of spontaneous and/or B95-8 EBV-induced B LCL. The cytotoxicity assay is a modification of a 4-h sodium 51Cr-chromate release assay described previously (12) . Briefly, effector cells were placed in round-bottom wells of a microtiter tray with 1 X 104 5'Crlabeled target cells at effector-to-target ratios ranging from 10:1 to 50:1 in 0.2 ml of RPMI 1640 and 10% FCS. The tray was spun at 200 g for 5 min, incubated for 4 h at 37°C in 5% CO2 atmosphere and then centrifuged at 200 g for 5 min. Aliquots (0.1 ml) of the supernatant were removed, placed in glass tubes and counted in a gamma counter. The percentage of specific lysis was calculated by the formula: ([experimental cpm -spontaneous cpm]/[maximal cpm -spontaneous cpm]) X 100%.
Bacteriophage q X174 studies and antibody determinations Bacteriophage OX174 was prepared as previously described (15) and given intravenously in a dose of 2.0 X 109 plaque-forming units/kg body wt. The secondary immunization was carried out 6 wk after the primary immunization. Antibodies to bacteriophage were determined by phage neutralization and expressed as the rate of inactivation of Kvalue (K,), as devised by a standard formula (15) . Isohemagglutinin titers were determined in the University of Massachusetts Medical Center Blood Bank. Quantitative immunoglobulins were determined by standard radial immunodiffusion or nephelometric techniques. Pneumococcal capsular polysaccharide antibodies were determined by a sensitive radioimmunoassay (16) . Viral antibodies (excluding EBV) were determined at the Massachusetts State Laboratory, Jamaica Plain, MA. Antibody titers to EBV-VCA, EA, and EBNA were determined by established methods (17, 18) . In each of these assays, EBV-uninfected cell lines served as controls for nonspecific fluorescence. Known positive and negative control sera were tested in parallel.
EBV studies
Spontaneous and B 95-8 LCL were established as previously described (19) . Touch preparations made from lymphoid tissues obtained at autopsy were fixed in acetone/ methanol and stained for the presence of EBNA by the method of Reedman and Klein (18) . Productive virus infection was tested by collecting supernatants from spontaneous LCL and incubating these with cord blood lymphocytes.
Cultures were observed weekly for 6 wk for evidence of transformation to an EBNA-positive LCL.
RESULTS
Studies in males before and during fatal EBV infection
Immunological studies. Table I summarizes 
to rubella immunization, and circulating antibodies to several pneumococcal polysaccharide serotypes. NK cell activity against the K562 cell line was assessed in case 2 before infection and found to be normal.
Both case 1 and case 2 demonstrated suppressed responses to mitogens and antigens during acute EBV infection, which is typical of normal individuals experiencing acute infectious mononucleosis (21) . Marked increases in serum IgM levels were also observed. Cytotoxicity for the EBV-infected B lymphoblastoid cell line 8392 and the NK-sensitive target K562 was present in each case during the acute EBV infection. Table II increase in the OKT.8 cytotoxic/suppressor cell subset, most of which expressed HLA-DR antigens as determined by staining with the p23, 30 antisera. Polyclonal B cells were present and 1-2% of these were infected with EBV as determined by EBNA staining (data not shown). After 5 d of methylprednisolone therapy, little change in the T cell subsets was apparent. With the addition of ATG, and an increase in the dose of methylprednisolone, the OKT.8 population declined in parallel with the decreased cytotoxic activity (Table II) . A marked polyclonal increase in B lymphocytes was noted with >50% of peripheral blood lymphocytes (PBL) expressing K or X light chains. The lymphocyte count was 7,500/mm3, reflecting a markedly increased absolute B lymphocyte count.
Autologous cell lines were obtained following the death of case 2 and these cells were utilized as targets in a cytotoxicity assay. Effector cells included previously frozen PBL and a T cell population that was expanded using lectin-free purified T cell growth factor (TCGF). Results are shown in Table IV . Both unexpanded PBMC and TCGF purified T cell populations showed significant cytotoxicity against autologous EBV-infected B cells, fibroblasts, and hepatocyte target cells. Surface marker analysis of the effector cell population showed them to express the OKT.8 antigen and characterization of this population with the monoclonal antibody HNK-1, which recognizes a human NK cell (23) , showed that one-third of the OKT.8 population expressed this antigen.
Virological studies. Acute EBV infection was well documented in each case by serology and demonstration of virus-infected B lymphocytes (Table V) Fig. 3 , where 40-50% of the cells are positive. This specimen was obtained on the last day of life. Autopsy revealed extensive lymphoproliferation and the liver was massively infiltrated with immunoblasts. A touch preparation of liver tissue stained for EBNA is shown in Fig. 4 membrane antigen, by spontaneous LCL from cases 1 and 2, was assayed by using these cell lines as target cells with cytotoxic effector cells derived from normal individuals in the acute phase of infectious mononucleosis. In each case, the spontaneous EBV-infected LCL were lysed to a similar degree as standard target cells used in these assays (12) . Lymphocyte preparations from each patient were challenged with Newcastle disease virus and Con A to induce alpha and gamma interferon production and found to be normal (data not shown).
Immunological studies in surviving males after acute EBV infection Cellular and humoral immune studies performed on cases 3, 4, 5, and 6 are summarized in Table VI . Lymphocyte surface marker analysis revealed relatively normal percentages of T and B lymphocytes. Enumeration of lymphocyte subsets demonstrated increased numbers of the OKT.8 (cytotoxic/suppressor) T cell subset. Lymphocyte populations identified with the monoclonal antibodies HNK.1 and OKM.1, both of which react with human NK cell populations, were normal. Assessment of quantitative immunoglobulins showed each individual to have abnormalities of one isotype and two of the four cases meet the criteria for the diagnosis of common variable immunodeficiency with normal numbers of B lymphocytes and decreased IgG levels. Lymphocyte proliferative responses to graded amounts of mitogens and antigens were abnormal in each of the four cases, with T cell prolif- eration being abnormal in all four and B cell proliferation being normal in three of four. In each individual studied, previous exposure to EBV was proved by one or more of the following criteria: history of infectious mononucleosis with positive heterophile antibody, establishment of an EBNA-positive LCL and presence of EBV-specific antibodies. Case 3 and 4, who have hypogammaglobulinemia, show very low levels of EBV VCA antibodies. Both of these individuals are receiving monthly gamma globulin therapy, which probably accounts for these low EBV antibody levels.
NK cell activity was decreased in three of the four cases each effector-to-target cell ratio (13) . Interferon treatment of effector cells resulted in small increases in cytotoxicity, but normal activity was never achieved. NK cell activity against herpes simplex virus-infected target cells (14) was tested in case 3 and case 4 and found to be depressed below normal (data not shown).
In an attempt to evaluate antibody production to specific antigens, we intravenously immunized three of the four cases with bacteriophage 4X174. These results are shown in Fig. 5 . Two of three responded normally to primary immunization and all three showed normal anamnestic responses after secondary immunization. Qualitative assessment of the immune response after secondary immunization revealed all three to be severely deficient in IgG production (case 3, 4%; case 4, 2%; and case 6, 4% (24) , NK cell defects (13) , and abnormalities in T lymphocyte subsets (25) . The results reported here suggest that defective immunoregulation of a subset of cytotoxic FIGURE 4 Case 2, liver touch preparation stained for EBNA (X400).
T cells, which are not HLA antigen restricted, may contribute to complex and varied clinical outcomes in male individuals with XLP. These data have been derived from the first prospective study of affected males with XLP before and during infection with EBV.
In the first case presented, clinical assessment and screening immunological studies before infection with EBV demonstrated an intact immune system. Normal in vivo responses to viral and bacterial antigens were documented. In vitro T lymphocyte responses to nonspecific mitogens and antigens were normal, as were B lymphocyte markers and quantitative immunoglobulins. After exposure to EBV, infection and dissemination of EBV-infected B lymphocytes occurred, which initiated a normal humoral response (IgM and IgG antibody against VCA) and a vigorous killer cell response that was directed against a variety of target cells regardless of histocompatibility type and expression of EBV-determined antigens. Coincident with this response was the appearance of hepatitis, which became progressively severe and ultimately caused hepatic necrosis and death. Immunosuppressive agents were not used in this patient until the terminal phases. The presence of cytotoxic cells throughout the course of illness may explain the absence of intense B cell proliferation (12) ; EBV-infected proliferating B lymphocytes being lysed by the killer-cell response, which also resulted in hepatocytoxicity.
Case 2 was also studied before experience with EBV and demonstrated normal humoral immunity and in vitro T lymphocyte responses. In addition, cytotoxicity studies revealed normal NK cell activity against the K562 and Daudi targets. Two relevant observations in this patient are the development at age 3.5 yr of a lymphosarcoma of the liver, which was cured with chemotherapy and subsequently at age 6.5 yr the development of uncomplicated varicella infection. It is unlikely that this patient's lymphoma was associated with EBV infection since at age 8 yr, when first studied by us, he lacked EBV antibody and a spontaneous EBV-infected LCL could not be established. Uncomplicated varicella infection is further evidence of normal immune function before acute EBV infection.
Cases 1 and 2 provide strong evidence that the immunological defect in XLP is limited to or triggered by infection with EBV. Cytotoxic cells were present in the peripheral blood of each patient during infection. These cytotoxic cells killed EBV-infected LCL, as well as fibroblasts. Killing of autologous hepatocytes was also observed in case 2 and suggest that the hep- can be generated during alloactivation (33) , coculture with tumor cells (34) , or innoculation with Interleukin 2 (35) . Recent cell-surface marker analysis of AK cells has shown them to bear the pan-T cell marker and the OKT.8 antigen (35). Abo et al. (36, 37) (12, 13, 21) . In addition, we have not observed any abnormality in the virus-B lymphocyte relationship, i.e., increased production of infectious virus, or resistance to killing by cytotoxic T cells. We have observed what appears to be an uncontrolled activation of anomalous and NK cells that can mediate lysis of autologous lymphoid and nonlymphoid targets. Our findings are consistent with the hypothesis that uncontrolled AK and NK activity results in fatal infectious mononucleosis or immune deficiency in those affected males surviving acute EBV infections. This mechanism would explain the variation in the severity of the immune deficiency observed within affected kindreds (3, 4) . These secondary immune deficits may predispose surviving males with XLP to increased numbers of bacterial infections and perhaps to lymphoreticular malignancies. Further studies are in progress to determine normal regulatory mechanisms for AK and NK cells activated during acute EBV-induced infectious mononucleosis in normal individuals. These studies may be helpful in our understanding of acquired immune deficiency in man.
